WeVote
Log In

Bill

Bill

HB 2823

AHCCCS; nonopioid drugs; formulary

57th Legislature - First Regular Session Introduced by Leo Biasiucci

HB 2823 requires Arizona's AHCCCS to prioritize nonopioid pain drugs in its insurance formulary to reduce opioid dependence and overdose deaths.

House Second Reading
0
WeVote Research Nonpartisan
Bill Summary · HB 2823

Legislative bill overview

HB 2823 would require Arizona's AHCCCS (Arizona Health Care Cost Containment System) to prioritize coverage of nonopioid pain management drugs in its formulary—the list of covered medications. The bill aims to expand access to alternative pain treatments as part of broader opioid reduction efforts.

Why is this important

Arizona, like most states, has faced significant opioid addiction and overdose deaths. Expanding formulary coverage for nonopioid alternatives could reduce reliance on opioids for pain management while potentially lowering overdose mortality. However, AHCCCS serves low-income Arizonans, making formulary decisions directly affect vulnerable populations' healthcare access and state budget constraints.

Potential points of contention

  • Cost implications: Expanding nonopioid drug coverage may increase AHCCCS expenditures, raising questions about budget sustainability and whether costs shift to taxpayers or reduce coverage elsewhere
  • Clinical efficacy debate: Medical professionals disagree on effectiveness of various nonopioid alternatives for different pain conditions; mandating formulary inclusion may prioritize policy goals over evidence-based prescribing
  • Insurance company flexibility: Requiring specific formulary structures could limit AHCCCS's ability to negotiate drug prices or adjust coverage based on emerging clinical data and budget realities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.